| Public Notice | Monitoring | N/A | N/A | Sep 9, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 6, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 29, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 29, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 16, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 16, 2025 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.088 | Jun 30, 2025 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.016 | Jun 30, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Jun 30, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| TTHM | Health-Based | N/A | 0.119 | Mar 31, 2025 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.119 | Mar 31, 2025 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.119 | Mar 31, 2025 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.119 | Mar 31, 2025 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.119 | Mar 31, 2025 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.015 | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Jan 23, 2025 | Active | N/A |
| TTHM | Health-Based | N/A | 0.15 | Dec 31, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.15 | Dec 31, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.15 | Dec 31, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.15 | Dec 31, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.15 | Dec 31, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.084 | Dec 31, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.084 | Dec 31, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.084 | Dec 31, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.015 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| TTHM | Health-Based | N/A | 0.084 | Dec 31, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.17 | Sep 30, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.17 | Sep 30, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.17 | Sep 30, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.17 | Sep 30, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.17 | Sep 30, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.13 | Sep 30, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.13 | Sep 30, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| TTHM | Health-Based | N/A | 0.13 | Sep 30, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| TTHM | Health-Based | N/A | 0.13 | Sep 30, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.227 | Jun 30, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.227 | Jun 30, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.227 | Jun 30, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.227 | Jun 30, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.227 | Jun 30, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.227 | Jun 30, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.015 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| TTHM | Health-Based | N/A | 0.152 | Jun 30, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.152 | Jun 30, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.152 | Jun 30, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.152 | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 4, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 4, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.205 | Mar 31, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.205 | Mar 31, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.205 | Mar 31, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.205 | Mar 31, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.205 | Mar 31, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.176 | Mar 31, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.176 | Mar 31, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.176 | Mar 31, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.176 | Mar 31, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.173 | Mar 31, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.173 | Mar 31, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.016 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| TTHM | Health-Based | N/A | 0.173 | Mar 31, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.016 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| TTHM | Health-Based | N/A | 0.173 | Mar 31, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.186 | Dec 31, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.186 | Dec 31, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.186 | Dec 31, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.186 | Dec 31, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.015 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| TTHM | Health-Based | N/A | 0.219 | Dec 31, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.015 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| TTHM | Health-Based | N/A | 0.219 | Dec 31, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.219 | Dec 31, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.219 | Dec 31, 2023 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 27, 2023 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 27, 2023 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 27, 2023 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 27, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 7, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 7, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 3, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 3, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.169 | Sep 30, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.169 | Sep 30, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.169 | Sep 30, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.169 | Sep 30, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.169 | Sep 30, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.173 | Sep 30, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.016 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| TTHM | Health-Based | N/A | 0.173 | Sep 30, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.173 | Sep 30, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.173 | Sep 30, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.173 | Sep 30, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.16 | Jun 30, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.16 | Jun 30, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.16 | Jun 30, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.16 | Jun 30, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.16 | Jun 30, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.16 | Jun 30, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.16 | Jun 30, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.109 | Jun 30, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.109 | Jun 30, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.015 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| TTHM | Health-Based | N/A | 0.109 | Jun 30, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.109 | Jun 30, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.109 | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.12 | Mar 31, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.12 | Mar 31, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.12 | Mar 31, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.12 | Mar 31, 2023 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.12 | Mar 31, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.016 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.017 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.017 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.017 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.017 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.019 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.019 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.019 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.019 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.018 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Mar 15, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 15, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.018 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Nov 18, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 18, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.114 | Sep 30, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.114 | Sep 30, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.114 | Sep 30, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.114 | Sep 30, 2021 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.017 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.017 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.017 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.017 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| TTHM | Health-Based | N/A | 0.16 | Jun 30, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.16 | Jun 30, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.16 | Jun 30, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.16 | Jun 30, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.16 | Jun 30, 2021 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.017 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.017 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.017 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.017 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| TTHM | Health-Based | N/A | 0.199 | Mar 31, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.199 | Mar 31, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.199 | Mar 31, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.199 | Mar 31, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.199 | Mar 31, 2021 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.016 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Mar 22, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 22, 2021 | Resolved | N/A |